Coulter

Alain Richard joins Specific Diagnostics as Head of Commercial Operations, EMEA

Wednesday, September 16, 2020 - 11:20pm

MOUNTAIN VIEW, Calif., Sept. 16, 2020 /PRNewswire-PRWeb/ -- Specific Diagnostics today announced the appointment of industry veteran Alain Richard to the position of Head of Commercial Operations, EMEA, ahead of its European market launch.

Key Points: 
  • MOUNTAIN VIEW, Calif., Sept. 16, 2020 /PRNewswire-PRWeb/ -- Specific Diagnostics today announced the appointment of industry veteran Alain Richard to the position of Head of Commercial Operations, EMEA, ahead of its European market launch.
  • Previously, as Vice President EMEA Mr. Richard helped build Iris Diagnostics' commercial business in Europe, where he was its first employee, to a $55M division of Iris before its acquisition by Danaher company Beckman Coulter in 2009.
  • Mr. Richard will play a similar role on the Specific leadership team, where he will be responsible for overseeing commercial operations in Europe.
  • "We are fortunate to have someone with Alain's knowledge and experience join our leadership team," said Dr. Paul A. Rhodes, CEO of Specific.

Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T

Tuesday, September 15, 2020 - 2:00pm

"The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics' portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular assessments of RBCs, WBCs and platelets.

Key Points: 
  • "The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics' portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular assessments of RBCs, WBCs and platelets.
  • Beckman Coulter designed the DxH 690T with medium-sized hospitals and mid-volume laboratories in mind to increase walkaway times, minimize touchpoints and maximize uptime.
  • Significantly, the DxH 690T also supports early detection of sepsis for adult patients in the emergency department with the Early Sepsis Indicator (ESId).
  • Unlike existing hematology analyzers, Beckman Coulter's DxH 690T includes ESId that extracts information about sepsis' presence through monocyte morphology.

Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T

Tuesday, September 15, 2020 - 2:00pm

"The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics' portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular assessments of RBCs, WBCs and platelets.

Key Points: 
  • "The DxH 690T leverages flagship products in the Beckman Coulter Diagnostics' portfolio, specifically the enhanced Coulter Principle, VCS technology and DataFusion, to provide precise cellular assessments of RBCs, WBCs and platelets.
  • Beckman Coulter designed the DxH 690T with medium-sized hospitals and mid-volume laboratories in mind to increase walkaway times, minimize touchpoints and maximize uptime.
  • Significantly, the DxH 690T also supports early detection of sepsis for adult patients in the emergency department with the Early Sepsis Indicator (ESId).
  • Unlike existing hematology analyzers, Beckman Coulter's DxH 690T includes ESId that extracts information about sepsis' presence through monocyte morphology.

Beckman Coulter's Automated Blood Banking Analyzer Receives 510(k) FDA Clearance

Thursday, July 23, 2020 - 1:00pm

BREA, Calif., July23, 2020 /PRNewswire/ --Beckman Coultertoday announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA)for its PK7400 Automated Microplate System and the system's reagents have completed FDA approval.

Key Points: 
  • BREA, Calif., July23, 2020 /PRNewswire/ --Beckman Coultertoday announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA)for its PK7400 Automated Microplate System and the system's reagents have completed FDA approval.
  • According to the AABB (formerly the American Association of Blood Banks), an estimated 33,000 units of blood are needed each day to meet patient need.
  • However, the organization also stated, more than 4,000 blood donation events have been cancelled due to the COVID-19 pandemic.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year

Tuesday, July 21, 2020 - 9:52pm

The awards were presented by SelectScience at the SelectScience Virtual Clinical Chemistry Summit, held July 20-22, 2020.

Key Points: 
  • The awards were presented by SelectScience at the SelectScience Virtual Clinical Chemistry Summit, held July 20-22, 2020.
  • "Our team is excited and honored to receive these awards from the scientific community," said Julie Sawyer Montgomery, president of Beckman Coulter.
  • Beckman Coulter received the Customer Service of the Year award for receiving consistently positive after-sales service feedback from clinical scientists via SelectScience reviewsin 2019.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Beckman Coulter Receives Nine IMV ServiceTrak™ Clinical Laboratory Awards

Friday, July 17, 2020 - 2:15pm

BREA, Calif., July 17, 2020 /PRNewswire/ --Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories.

Key Points: 
  • BREA, Calif., July 17, 2020 /PRNewswire/ --Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories.
  • "We are excited and proud to congratulate Beckman Coulter on its nine awards including Best System Performance, Best Service and Best Customer Satisfaction.
  • ServiceTrak Clinical Laboratory Awards are based on interviews conducted with respondents in 2,229 clinical testing locations having 5,117 instruments.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Beckman Coulter's SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization

Monday, June 29, 2020 - 1:00pm

BREA, Calif., June29, 2020 /PRNewswire/ -- Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA).

Key Points: 
  • BREA, Calif., June29, 2020 /PRNewswire/ -- Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA).
  • Beckman Coulter has already shipped tests to more than 400 hospitals, clinics and diagnostics laboratories in the U.S., and has begun distribution of the new antibody test globally to countries that accept the FDA EUA and CE Mark.
  • Henry Ford Health System was one of the first health systems to receive Beckman Coulter's test and independently validate its performance.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Beckman Coulter's SARS-CoV-2 IgG antibody test now available in markets accepting the CE Mark

Monday, June 15, 2020 - 8:00am

BREA, California, June 15, 2020 /PRNewswire/ --Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark.

Key Points: 
  • BREA, California, June 15, 2020 /PRNewswire/ --Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark.
  • Henry Ford Health System was one of the first health systems to receive Beckman Coulter's test and independently validate its performance.
  • The Beckman Coulter Access SARS-CoV-2 IgG assay detects immunoglobulin G (IgG), and targets antibodies that recognize the receptor-binding domain (RBD) of the spike protein which SARS-CoV-2 uses to bind to a human cell receptor.
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In EUA-Authorized COVID-19 Test

Thursday, May 28, 2020 - 5:06pm

Beckman Coulter Life Sciences has remained committed to developing high-performing, scalable reagents for laboratories testing COVID-19 patient swab samples.

Key Points: 
  • Beckman Coulter Life Sciences has remained committed to developing high-performing, scalable reagents for laboratories testing COVID-19 patient swab samples.
  • "RNA extraction is essential today for reliable COVID-19 testing," said Thomas Marshall, Ph.D., Genomics R&D Leader, Beckman Coulter Life Sciences.
  • In March, Beckman Coulter Life Sciences published two demonstrated RNA extraction methods for viral samples.
  • Beckman Coulter Life Sciences is an operating company within Danaher Corporation's (NYSE: DHR) Life Sciences platform.

Beckman Coulter launches DxH 690T mid-volume hematology analyzer, featuring the Early Sepsis Indicator in U.S. market

Monday, May 18, 2020 - 4:49pm

BREA, Calif., May 18, 2020 /PRNewswire/ -- Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S.

Key Points: 
  • BREA, Calif., May 18, 2020 /PRNewswire/ -- Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S.
  • The DxH 690T brings mid-volume laboratories advanced features such as the Early Sepsis Indicator (ESId) available on Beckman Coulter's larger high-volume analyzer, the DxH900.
  • The DxH 690T also supports standardization across hospital networks to a single platformDxH 900 for larger-volume labs and DxH 690T for mid-volume."
  • Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.